Catherine Sohn

Sohn Health Strategies LLC provides business development and new product marketing consulting services. The American company was founded by Catherine Angell Sohn.

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

CHD Bioscience, Inc. develops and manufactures disinfectants for healthcare and food industries. The company is headquartered in Fort Collins, CO.

EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA.

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.

Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ.

The World Self-Medication Industry Association is a non-profit, voluntary association that contributes to WHO's public health goals through its specialized expertise in self-care and responsible self-medication with non-prescription medicines. The association is based in Nyon, Switzerland. The association is a member of the UHC2030 Private Sector Constituency and supports the recent Private Sector Statement that was initiated by the World Economic Forum. The association calls on governments and policymakers to take measures to improve the overall integration of self-care into national health policies.

Licensing Executives Society USA & Canada, Inc. is an association that operates for intellectual property, technology, and business development professionals. The non-profit company is based in Reston, VA. The company was founded in 1965.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare LP produces and markets consumer healthcare products.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA.

Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA.